Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Diffuse Midline Glioma
Related studies linked through entity extraction aliases.
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2